Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07022392 · ClinicalTrials.gov registry record · NA
Feasibility and Acceptability of the Technology Based Enhanced Gender Support Platform Implementation With Parents
A NA study, sponsored by Seattle Children's Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT07022392 is a NA study that has not yet begun recruiting, run by Seattle Children's Hospital. The registered enrollment target is 36 participants.
The verdict
NCT07022392, a NA study, has not yet begun recruiting, sponsored by Seattle Children's Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a small pilot feasibility and acceptability study of implementing a Technology-Enhanced Gender Support (TEGS) platform with parents and caregivers. Parents and caregivers who consent to participate will complete an electronic survey at baseline. They will then receive access to the TEGS platform and complete follow up surveys 1 mo and 3 mo after. Each participant will also be given the option to participate in an exit interview.
Interventions
- OTHER Technology-enhanced gender support platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07022392
The ClinicalTrials.gov registry entry for NCT07022392 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Technology-enhanced gender support platform is the first listed.
NCT07022392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07022392 about?
NCT07022392 is a clinical study titled "Feasibility and Acceptability of the Technology Based Enhanced Gender Support Platform Implementation With Parents". This is a small pilot feasibility and acceptability study of implementing a Technology-Enhanced Gender Support (TEGS) platform with parents and caregivers. Parents and caregivers who consent to participate will complete an electronic survey at baseline. They will then receive access to the TEGS plat...
What is the current status of trial NCT07022392?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-10-01. Estimated completion is 2026-03-31.
What interventions are being tested in trial NCT07022392?
The interventions under investigation include: Technology-enhanced gender support platform (OTHER).
Who is sponsoring clinical trial NCT07022392?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.